Yin Yin Lin

Title: Innovations of Yin Yin Lin in CTLA4-Fc Fusion Proteins

Introduction

Yin Yin Lin is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods related to CTLA4-Fc fusion proteins. His work has implications for therapeutic applications, including the well-known drug abatacept.

Latest Patents

Yin Yin Lin holds a patent for methods related to CTLA4-Fc fusion proteins. The present disclosure provides, in part, methods for evaluating, identifying, and/or producing a CTLA4-Fc fusion protein, such as abatacept. These methods allow for highly resolved evaluation of abatacept, which is useful for manufacturing, characterizing, identifying, confirming, monitoring the structure, and comparing abatacept preparations made over time or under different conditions.

Career Highlights

Yin Yin Lin is currently employed at Momenta Pharmaceuticals, Inc., where he continues to advance his research in the field of fusion proteins. His innovative approaches have contributed to the understanding and development of therapeutic proteins.

Collaborations

Yin Yin Lin collaborates with notable colleagues, including John Robblee and Xiaomei He, who contribute to the research and development efforts at Momenta Pharmaceuticals, Inc.

Conclusion

Yin Yin Lin's work in the field of CTLA4-Fc fusion proteins exemplifies the impact of innovative research in biotechnology. His contributions are paving the way for advancements in therapeutic applications, showcasing the importance of collaboration and innovation in the scientific community.